<DOC>
	<DOCNO>NCT03074838</DOCNO>
	<brief_summary>A control un-randomized trial inflammatory response 18 patient admit TAVI procedure compare inflammatory response 18 patient admitted conventional surgical valve replacement . Clinical outcome record compare Groups . As secondary endpoint , inflammatory response also compare patient receive either transfemoral trans aortal TAVI .</brief_summary>
	<brief_title>Inflammatory Response Aortic Valve Replacement</brief_title>
	<detailed_description>18 patient admit successively conventional surgical aortic valve replacement 18 patient admitted transcatheter aortic valve implantation ( TAVI ) ( 9 transfemoral 9 transaortic ) include . A plasma sample obtain defined timepoints , surgery . At time point follow biomarkers analyze : Concentrations complement activation product C3bc terminal C5b-9 complement complex ( TCC ) , neutrophil release product myeloperoxidase ( MPO ) , cytokines IL-6 , eotaxin , MCP-1 MIP-1Î² ( 12 ) . As marker myocardial cellular injury troponin T level analyze . The following clinical outcome also monitor : Death ( hospital , 30 day one year ) , blood transfusion , stroke , myocardial infarction . A dedicated registry establish hospital accord hospital 's standard storage patient data . The registry delete completion study .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Patients eligible aortic valve replacement without need concurrent surgery know inflammatory disease antiinflammatory treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>TAVI</keyword>
</DOC>